Home » Newsletters » BioWorld Science

BioWorld Science

June 19, 2013

View Archived Issues

New results reported in murine model of spinocerebellar ataxia

Isis Pharmaceuticals presents phase I data for ISIS-PTP-1BRx

Preclinical results and initiation of first-in-human trial of ATROSAB

Preclinical evaluation of miRNA inhibitor in severe PAH

PsychoGenics and Sunovion Pharmaceuticals expand CNS partnership

Genmab and ADC Therapeutics collaborate on antibody-drug conjugate

Genocea Biosciences prepares new vaccines for HSV-2 infection

First patient dosed in phase III study of Zubsolv for new indication

Amgen presents phase I results for AMG-181 in patients with Crohn's disease and ulcerative colitis

Fluvoxamine maleate enters Japanese phase III trial for pediatric OCD

DaVita and Myriad establish protein biomarker discovery collaboration

Additive therapy with ESKM leads to complete eradication of tumors in vivo

WHO issues interim guidance on bedaquiline for pulmonary multidrug-resistant TB

New EP2 receptor antagonists patented by Bayer

Civitas Therapeutics receives second Michael J. Fox Foundation grant for CVT-301

Beta Pharma presents novel HDAC6 inhibitors

Phenex Pharmaceuticals designs new RORgamma ligands

iCo Therapeutics completes enrollment in phase II iDEAL trial

Chinese researchers patent novel alpha1A-adrenoceptor antagonists

PhaseBio expands clinical development of Vasomera for cardiopulmonary diseases

Novel PARP-1 inhibitors presented by Chengdu Di'ao Pharmaceutical Group

MEI Pharma commences phase II trial of pracinostat and Vidaza in frontline MDS

ViroMed advances in phase II trial of VM-202-DPN

FDA obtains license from GVK Biosciences for GOSTAR database

Oxygen Biotherapeutics gives update on Oxycyte

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...